Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)
| Autor: | Watson, S., de la Fouchardière, C., Kim, S., Cohen, R., Bachet, J.B., Tournigand, C., Ferraz, J.M., Lefevre, M., Colin, D., Svrcek, M., Meurisse, A., Louvet, C. |
|---|---|
| Zdroj: | In European Journal of Cancer January 2019 107:46-52 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect